Health-related quality of life, mental and sleep disordes of patients with pulmonary arterial hypertension participating in the Polish PH treatment program
Pulmonary arterial hypertension (PAH) is a rare, chronic disease, that leads to the development of a range of heart failure-related symptoms that directly affect an individual's functioning. The aim of the study was to assess health-related quality of life (HRQoL) of the PAH patients. Particip...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Kazimierz Wielki University
2025-01-01
|
Series: | Journal of Education, Health and Sport |
Subjects: | |
Online Access: | https://apcz.umk.pl/JEHS/article/view/56684 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841556522792910848 |
---|---|
author | Kathie Sarzyńska Beata Jankowska-Polańska |
author_facet | Kathie Sarzyńska Beata Jankowska-Polańska |
author_sort | Kathie Sarzyńska |
collection | DOAJ |
description |
Pulmonary arterial hypertension (PAH) is a rare, chronic disease, that leads to the development of a range of heart failure-related symptoms that directly affect an individual's functioning. The aim of the study was to assess health-related quality of life (HRQoL) of the PAH patients. Participants completed several specific survey questionnaires. The mean scores obtained in each domain of the PAH-SYMPACT HRQoL questionnaire were: cardiopulmonary symptoms 1.02±0.57, cardiovascular symptoms 0.54±0.5, physical effects 1.24±0.9, mental effects 0.99±SD=0.82. The average scores on the anxiety and depression scales were 5.33±3.31, 4.4±3.78, respectively, which indicates their low severity. The mean score obtained on the Pittsburgh Sleep Quality Scale (PSQI) was 8.7±4.64 and represented the to poor sleep quality affecting the study group. Sleep disorders were present in the majority of the subjects and had the most significant impact on reducing the HRQoL in the study group. Anxiety and depressive disorders were present in a small percentage of the subjects. The results showed that the best predictor of HRQoL evaluation is sleep quality assessment.
|
format | Article |
id | doaj-art-b257cecad6ae4836ad5d09aaf6e4c969 |
institution | Kabale University |
issn | 2391-8306 |
language | English |
publishDate | 2025-01-01 |
publisher | Kazimierz Wielki University |
record_format | Article |
series | Journal of Education, Health and Sport |
spelling | doaj-art-b257cecad6ae4836ad5d09aaf6e4c9692025-01-07T08:16:39ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062025-01-017710.12775/JEHS.2025.77.56684Health-related quality of life, mental and sleep disordes of patients with pulmonary arterial hypertension participating in the Polish PH treatment programKathie Sarzyńska0https://orcid.org/0000-0003-0470-354XBeata Jankowska-Polańska1https://orcid.org/0000-0003-1120-3535Department of Nursing and Midwifery, Wroclaw Medical UniversityFaculty of Medicine, Technical University of Wroclaw, 50-370 Wroclaw, Poland; Research and Innovation Center, 4th Military Teaching Hospital, 50-981 Wroclaw, Poland Pulmonary arterial hypertension (PAH) is a rare, chronic disease, that leads to the development of a range of heart failure-related symptoms that directly affect an individual's functioning. The aim of the study was to assess health-related quality of life (HRQoL) of the PAH patients. Participants completed several specific survey questionnaires. The mean scores obtained in each domain of the PAH-SYMPACT HRQoL questionnaire were: cardiopulmonary symptoms 1.02±0.57, cardiovascular symptoms 0.54±0.5, physical effects 1.24±0.9, mental effects 0.99±SD=0.82. The average scores on the anxiety and depression scales were 5.33±3.31, 4.4±3.78, respectively, which indicates their low severity. The mean score obtained on the Pittsburgh Sleep Quality Scale (PSQI) was 8.7±4.64 and represented the to poor sleep quality affecting the study group. Sleep disorders were present in the majority of the subjects and had the most significant impact on reducing the HRQoL in the study group. Anxiety and depressive disorders were present in a small percentage of the subjects. The results showed that the best predictor of HRQoL evaluation is sleep quality assessment. https://apcz.umk.pl/JEHS/article/view/56684Health-related quality of life (HRQoL)pulmonary arterial hypertension (PAH) |
spellingShingle | Kathie Sarzyńska Beata Jankowska-Polańska Health-related quality of life, mental and sleep disordes of patients with pulmonary arterial hypertension participating in the Polish PH treatment program Journal of Education, Health and Sport Health-related quality of life (HRQoL) pulmonary arterial hypertension (PAH) |
title | Health-related quality of life, mental and sleep disordes of patients with pulmonary arterial hypertension participating in the Polish PH treatment program |
title_full | Health-related quality of life, mental and sleep disordes of patients with pulmonary arterial hypertension participating in the Polish PH treatment program |
title_fullStr | Health-related quality of life, mental and sleep disordes of patients with pulmonary arterial hypertension participating in the Polish PH treatment program |
title_full_unstemmed | Health-related quality of life, mental and sleep disordes of patients with pulmonary arterial hypertension participating in the Polish PH treatment program |
title_short | Health-related quality of life, mental and sleep disordes of patients with pulmonary arterial hypertension participating in the Polish PH treatment program |
title_sort | health related quality of life mental and sleep disordes of patients with pulmonary arterial hypertension participating in the polish ph treatment program |
topic | Health-related quality of life (HRQoL) pulmonary arterial hypertension (PAH) |
url | https://apcz.umk.pl/JEHS/article/view/56684 |
work_keys_str_mv | AT kathiesarzynska healthrelatedqualityoflifementalandsleepdisordesofpatientswithpulmonaryarterialhypertensionparticipatinginthepolishphtreatmentprogram AT beatajankowskapolanska healthrelatedqualityoflifementalandsleepdisordesofpatientswithpulmonaryarterialhypertensionparticipatinginthepolishphtreatmentprogram |